Clarametyx Biosciences Expands Team Expertise to Accelerate Pipeline Momentum
Steve St. Onge, PharmD, MBA appointed Senior Vice President of Corporate…
Clarametyx Biosciences Announces $33 Million Series A Financing to Advance Anti-Biofilm Biologics for Serious Bacterial Infections
Newly established relationship with Cystic Fibrosis Foundation enables…